Recent Quarter Total Invested
$17.42 M
Recent Quarter Institutional Ownership Percentage
27.92%
Total Invested of Last Quarter
$30.98 M
Ownership Percentage of Last Quarter
35.82%
Cue Biopharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLEICHROEDER LP | 08/13/2024 | 2.86 M | $3.55 M | 3.87% | 5.78% |
| SLATE PATH CAPITAL LP | 08/14/2024 | 2.40 M | $2.98 M | 0.00% | 4.86% |
| VANGUARD GROUP INC | 08/13/2024 | 2.03 M | $2.52 M | -11.03% | 4.11% |
| BLACKROCK INC. | 08/13/2024 | 756,736 | $938,353 | -66.28% | 1.53% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 493,987 | $612,544 | 36.43% | 1.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 492,456 | $610,794 | -41.27% | 1.00% |
| ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC | 08/13/2024 | 478,500 | $593,340 | 0.00% | 0.97% |
| NORTHERN TRUST CORP | 08/14/2024 | 350,419 | $434,519 | -4.04% | 0.71% |
| GOOD LIFE ADVISORS, LLC | 07/18/2024 | 325,000 | $403,001 | 225.00% | 0.66% |
| GSA CAPITAL PARTNERS LLP | 08/15/2024 | 277,559 | $344,000 | 32.74% | 0.56% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 266,373 | $330,302 | 483.66% | 0.54% |
| SIGMA PLANNING CORP | 08/06/2024 | 266,030 | $329,877 | 3.92% | 0.54% |
| ADVISORY RESEARCH INC | 08/13/2024 | 257,225 | $318,959 | 0.00% | 0.52% |
| MONACO ASSET MANAGEMENT SAM | 08/07/2024 | 253,185 | $313,949 | -24.36% | 0.51% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 242,568 | $300,784 | -0.43% | 0.49% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 214,089 | $265,758 | -50.36% | 0.43% |
| STIFEL FINANCIAL CORP | 08/13/2024 | 193,990 | $240,546 | 0.73% | 0.39% |
| STATE STREET CORP | 08/14/2024 | 177,053 | $219,546 | -76.70% | 0.36% |
| Y-INTERCEPT (HONG KONG) LTD | 08/14/2024 | 153,632 | $190,504 | 100.00% | 0.31% |
| MORGAN STANLEY | 08/14/2024 | 120,999 | $150,039 | -19.27% | 0.24% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 119,722 | $148,455 | 255.73% | 0.24% |
| JANE STREET GROUP, LLC | 08/15/2024 | 98,608 | $122,274 | 100.00% | 0.20% |
| BAKER AVENUE ASSET MANAGEMENT, LP | 08/08/2024 | 93,320 | $115,717 | 188.22% | 0.19% |
| HIGHTOWER ADVISORS, LLC | 08/13/2024 | 83,284 | $103,000 | 7.46% | 0.17% |
| CITADEL ADVISORS LLC | 08/14/2024 | 83,277 | $103,263 | -43.05% | 0.17% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 80,234 | $99,490 | 100.00% | 0.16% |
| CENTIVA CAPITAL, LP | 08/14/2024 | 66,894 | $82,949 | 100.00% | 0.14% |
| UBS GROUP AG | 08/14/2024 | 59,016 | $73,180 | -36.52% | 0.12% |
| SQUAREPOINT OPS LLC | 08/14/2024 | 57,318 | $71,074 | -50.65% | 0.12% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 09/16/2024 | 53,027 | $65,753 | 100.00% | 0.11% |
| HRT FINANCIAL LP | 08/12/2024 | 52,828 | $65,000 | 100.00% | 0.11% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 43,300 | $53,692 | 100.00% | 0.09% |
| PALOMA PARTNERS MANAGEMENT CO | 08/14/2024 | 32,595 | $40,418 | 100.00% | 0.07% |
| NAVALIGN, LLC | 07/30/2024 | 25,000 | $31,000 | 0.00% | 0.05% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 24,000 | $29,760 | 100.00% | 0.05% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 07/26/2024 | 22,200 | $28,000 | 0.00% | 0.04% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 20,683 | $25,646 | -33.04% | 0.04% |
| GROUND SWELL CAPITAL, LLC | 08/07/2024 | 18,428 | $22,851 | 100.00% | 0.04% |
| BARCLAYS PLC | 08/14/2024 | 18,298 | $22,000 | -41.73% | 0.04% |
| LPL FINANCIAL LLC | 08/07/2024 | 17,925 | $22,227 | 38.68% | 0.04% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 08/14/2024 | 17,897 | $22,192 | 100.00% | 0.04% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 17,072 | $21,169 | -81.35% | 0.03% |
| SEACREST WEALTH MANAGEMENT, LLC | 07/22/2024 | 13,000 | $16,120 | 0.00% | 0.03% |
| CITADEL ADVISORS LLC | 08/14/2024 | 12,800 | $15,872 | -0.78% | 0.03% |
| DOHENY ASSET MANAGEMENT /CA | 08/07/2024 | 12,660 | $310,000 | 100.00% | 0.03% |
| POINT72 (DIFC) LTD | 09/16/2024 | 11,527 | $14,293 | 100.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 11,381 | $14,113 | 248.26% | 0.02% |
| CITADEL ADVISORS LLC | 08/14/2024 | 11,100 | $13,764 | 76.19% | 0.02% |
| TOROSO INVESTMENTS, LLC | 08/14/2024 | 10,786 | $13,374 | -7.11% | 0.02% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 10,744 | $13,323 | 100.00% | 0.02% |
Cue Biopharma, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CUE shares?
During the previous two years, 107 institutional investors and hedge funds held shares of Cue Biopharma, Inc.. The most heavily invested institutionals were:
Bleichroeder LP: 2.86 M
Slate Path Capital LP: 2.4 M
VANGUARD GROUP INC: 2.03 M
BlackRock Inc.: 756,736
MILLENNIUM MANAGEMENT LLC: 493,987
GEODE CAPITAL MANAGEMENT, LLC: 492,456
-
What percentage of Cue Biopharma, Inc. stock is owned by institutional investors?
27.92% of Cue Biopharma, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CUE ?
Institutional investors have bought a total of 13.98 M shares in the last 24 months. This purchase volume represents approximately $16.22 M in transactions.